- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04317989
STUN (STop UNhealthy) Alcohol Use Now! Implementing Evidence-Based Services for Unhealthy Alcohol Use in Primary Care (STUN)
The STUN (STop UNhealthy) Alcohol Use Now! Project: Using Practice Facilitation to Disseminate and Implement Patient-Centered Outcomes Research (PCOR) Evidence on Screening and Management of Unhealthy Alcohol Use in Primary Care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
STUN Alcohol Use Now is an intervention designed to use primary care practice support services (practice facilitation or PF) to help small to medium-size practices (10 or fewer providers) identify and provide services for people with unhealthy alcohol use. 135 primary care practices in North Carolina will be recruited.
Specific Aim 1 will evaluate the effect of PF on uptake of evidence-based screening and brief intervention (SBI) for unhealthy alcohol use. The investigators hypothesize that PF will increase screening for unhealthy alcohol use and provision of brief counseling. The secondary hypothesis is that practice-level and contextual factors (capacity for quality improvement, organizational readiness to implement change, and implementation climate) will moderate the effect of PF on use of evidence-based screening and brief intervention (SBI) for unhealthy alcohol use.
Specific Aim 2 will evaluate whether PF increases provision, among those identified as having an alcohol use disorder (AUD), provision of medication assisted treatment (MAT) or referral to specialty care.
Aim 3 (effect of providing embedded telehealth services) will not be evaluated due to lower enrollment than anticipated and delayed data collection (both related to the COVID-19 pandemic) which have prevented randomization among practices with slower uptake of SBI after 6 months of PF.
In Aim 4 the investigators will evaluate the effect of PF on the implementation of clinical practice and office systems changes to improve evidence-based SBI and MAT. The primary hypothesis is that PF will increase implementation of clinical practice and office systems changes to improve evidence-based SBI and MAT. The secondary hypotheses are that (a) practice capacity for quality improvement (QI), organizational readiness to implement change, and contextual factors will moderate the effect of PF on the implementation of clinical practice and office systems changes and (b) embedded telehealth services will increase implementation of clinical practice and office systems changes among practices with slower uptake.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Asheville, North Carolina, United States, 28803-2868
- Mountain AHEC
-
Charlotte, North Carolina, United States, 28232
- Charlotte AHEC
-
Greensboro, North Carolina, United States, 27401
- Greensboro AHEC
-
Greenville, North Carolina, United States, 27835
- Eastern AHEC
-
Raleigh, North Carolina, United States, 27604-1657
- Wake AHEC
-
Rocky Mount, North Carolina, United States, 27804-0368
- Area L AHEC
-
Wilmington, North Carolina, United States, 28403
- Southeast AHEC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Small-to-medium sized primary care practices (10 or fewer providers) in North Carolina
Exclusion Criteria:
- Practices with fewer than 100 adult patients (18+ years) or more than 10 providers;
- practices unwilling to implement evidence-based screening and management of patients with unhealthy alcohol use.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Practice Facilitation
All enrolled practices will receive practice facilitation for the duration of the intervention period.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of adults screened for unhealthy alcohol use
Time Frame: 18 months
|
number aged 18 or older who were screened with a validated tool for unhealthy alcohol use
|
18 months
|
Number of adults screened for unhealthy alcohol use
Time Frame: 12 months
|
number aged 18 or older who were screened with a validated tool for unhealthy alcohol use
|
12 months
|
Number of adults screened for unhealthy alcohol use
Time Frame: 6 months
|
number aged 18 or older who were screened with a validated tool for unhealthy alcohol use
|
6 months
|
Percent of adults screened for unhealthy alcohol use
Time Frame: 18 months
|
percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use
|
18 months
|
Percent of adults screened for unhealthy alcohol use
Time Frame: 12 months
|
percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use
|
12 months
|
Percent of adults screened for unhealthy alcohol use
Time Frame: 6 months
|
percent of those aged 18 or older who were screened with a validated tool for unhealthy alcohol use
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of adults with a positive screen for unhealthy alcohol use
Time Frame: 18 months
|
Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result
|
18 months
|
Number of adults with a positive screen for unhealthy alcohol use
Time Frame: 12 months
|
Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result
|
12 months
|
Number of adults with a positive screen for unhealthy alcohol use
Time Frame: 6 months
|
Of those aged 18 or older who were screened for unhealthy alcohol use, number who had a positive initial screening result
|
6 months
|
Percent of adults with a positive screen for unhealthy alcohol use
Time Frame: 18 months
|
Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result
|
18 months
|
Percent of adults with a positive screen for unhealthy alcohol use
Time Frame: 12 months
|
Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result
|
12 months
|
Percent of adults with a positive screen for unhealthy alcohol use
Time Frame: 6 months
|
Of those aged 18 or older who were screened for unhealthy alcohol use, percentage who had a positive initial screening result
|
6 months
|
Number of adults provided with brief counseling for risky drinking
Time Frame: 18 months
|
Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record)
|
18 months
|
Number of adults provided with brief counseling for risky drinking
Time Frame: 12 months
|
Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record)
|
12 months
|
Number of adults provided with brief counseling for risky drinking
Time Frame: 6 months
|
Of those aged 18 or older who were identified as having unhealthy alcohol use, number who received brief counseling (based on documentation in the medical record)
|
6 months
|
Percent of adults provided with brief counseling for risky drinking
Time Frame: 18 months
|
Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record)
|
18 months
|
Percent of adults provided with brief counseling for risky drinking
Time Frame: 12 months
|
Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record)
|
12 months
|
Percent of adults provided with brief counseling for risky drinking
Time Frame: 6 months
|
Of those aged 18 or older who were identified as having unhealthy alcohol use, percentage who received brief counseling (based on documentation in the medical record)
|
6 months
|
Number of adults identified as having alcohol use disorder (AUD)
Time Frame: 18 months
|
After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD)
|
18 months
|
Number of adults identified as having alcohol use disorder (AUD)
Time Frame: 12 months
|
After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD)
|
12 months
|
Number of adults identified as having alcohol use disorder (AUD)
Time Frame: 6 months
|
After screening, number of adult patients identified to have AUD (based on documented ICD diagnoses of AUD)
|
6 months
|
Percent of adults identified as having alcohol use disorder (AUD)
Time Frame: 18 months
|
After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD)
|
18 months
|
Percent of adults identified as having alcohol use disorder (AUD)
Time Frame: 12 months
|
After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD)
|
12 months
|
Percent of adults identified as having alcohol use disorder (AUD)
Time Frame: 6 months
|
After screening, percentage of adult patients screened who were identified to have AUD (based on documented ICD diagnoses of AUD)
|
6 months
|
Number of adults prescribed pharmacotherapy for AUD
Time Frame: 18 months
|
After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
|
18 months
|
Number of adults prescribed pharmacotherapy for AUD
Time Frame: 12 months
|
After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
|
12 months
|
Number of adults prescribed pharmacotherapy for AUD
Time Frame: 6 months
|
After screening, number of adult patients with AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
|
6 months
|
Percent of adults with AUD who were prescribed pharmacotherapy for AUD
Time Frame: 18 months
|
After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
|
18 months
|
Percent of adults with AUD who were prescribed pharmacotherapy for AUD
Time Frame: 12 months
|
After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
|
12 months
|
Percent of adults with AUD who were prescribed pharmacotherapy for AUD
Time Frame: 6 months
|
After screening, percent of adult patients identified as having AUD who receive evidence-based pharmacotherapy with naltrexone, acamprosate, disulfiram, or topiramate
|
6 months
|
Number of adults with AUD referred to specialty care for AUD
Time Frame: 18 months
|
After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
|
18 months
|
Number of adults with AUD referred to specialty care for AUD
Time Frame: 12 months
|
After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
|
12 months
|
Number of adults with AUD referred to specialty care for AUD
Time Frame: 6 months
|
After screening, number of adult patients identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
|
6 months
|
Percent of adults with AUD referred to specialty care for AUD
Time Frame: 18 months
|
After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
|
18 months
|
Percent of adults with AUD referred to specialty care for AUD
Time Frame: 12 months
|
After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
|
12 months
|
Percent of adults with AUD referred to specialty care for AUD
Time Frame: 6 months
|
After screening, percentage of adults identified as having AUD who are referred to specialty care (e.g., psychiatry, CBT, motivational enhancement therapy, 12-step programs)
|
6 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Daniel E Jonas, MD, MPH, Ohio State University
- Principal Investigator: Darren Dewalt, MD, MPH, UNC Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-1853
- 1R18HS027078-01 (U.S. AHRQ Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Use Disorder
-
Washington State UniversityRecruitingNicotine Use Disorder | Alcohol Use Disorder (AUD)United States
-
University of North Carolina, Chapel HillCompletedAlcohol Use Disorder, Mild | Alcohol Use Disorder, ModerateUnited States
-
Université du Québec à Trois-RivièresCompletedAlcohol Use, Unspecified | Alcohol Use Disorder, MildCanada
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Kaiser PermanenteNORC at the University of Chicago; Agency for Healthcare Research and Quality... and other collaboratorsCompleted
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Central Institute of Mental Health, MannheimNot yet recruitingAlcohol Use Disorder (AUD)Germany
-
Massachusetts General HospitalMbarara University of Science and TechnologyCompletedAlcohol Use Disorder (AUD)Uganda
-
ITAB - Institute for Advanced Biomedical TechnologiesNot yet recruitingNeurobiological Effects of Transcranial Direct Current Stimulation Treatment in Alcohol Use DisorderAlcohol Dependence | Alcohol-Related Disorders | Substance Use Disorders | Drug Abuse | Mental Disorder | Alcohol Abuse | Alcohol Use Disorder (AUD)
Clinical Trials on Practice Facilitation
-
Northwestern UniversityUniversity of Utah; Pastors 4 PCORNot yet recruitingHypertensionUnited States
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)RecruitingHIV | Primary Prevention | Women's Health | Implementation Science | Intravenous Substance Abuse | Organization and AdministrationUnited States
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Kintampo Health Research Centre, GhanaNational Heart, Lung, and Blood Institute (NHLBI); NYU Langone Health; Kwame... and other collaboratorsActive, not recruitingCardiovascular Diseases | Hypertension | High Blood PressureGhana
-
University of Colorado, DenverCompleted
-
University of KentuckyNational Cancer Institute (NCI)Enrolling by invitation
-
University of Alabama at BirminghamUS Department of Veterans Affairs; Agency for Healthcare Research and Quality...RecruitingUrinary IncontinenceUnited States
-
VA Palo Alto Health Care SystemCompleted
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Active, not recruitingBreast Cancer | Colorectal Cancer | Lung Cancer | Prostate CancerUnited States
-
Oregon Health and Science UniversityAmerican Cancer Society, Inc.; University of Arkansas; Oregon Health AuthorityActive, not recruitingHuman Papilloma VirusUnited States